BLOOMBERG | The Year Ahead 2024
New Weight-Loss Drugs Like Wegovy Will Supercharge Pharma Revenue
新的减肥药物像Wegovy将激发制药收入。
2024-01-11 词
The boom helped fuel huge gains for shares of , maker of Ozempic and Wegovy, and (Mounjaro). They’re now among the most expensive Big Pharma stocks.
免责声明：本文来自网络公开资料，仅供学习交流，其观点和倾向不代表本站立场。